Gündoğdu, Y. Et Al. 2022. Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2 , 516-518.

Gündoğdu, Y., Deniz, O. C., Saka, D., Şişman, G., Erdamar, S., & Köksal, I., (2022). Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2, 516-518.

Gündoğdu, Yasemin Et Al. "Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2, 516-518, 2022

Gündoğdu, Yasemin Et Al. "Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2, pp.516-518, 2022

Gündoğdu, Y. Et Al. (2022) . "Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2, pp.516-518.

@article{article, author={Yasemin Gündoğdu Et Al. }, title={Sunitinib induced colitis manifesting as invasive diarrhea in a patient with renal cell carcinoma.}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year=2022, pages={516-518} }